HSIC Stock Overview
Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 2/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Henry Schein, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$73.11 |
| 52 Week High | US$89.72 |
| 52 Week Low | US$64.75 |
| Beta | 0.81 |
| 1 Month Change | -4.87% |
| 3 Month Change | -8.76% |
| 1 Year Change | 9.32% |
| 3 Year Change | 22.57% |
| 5 Year Change | -15.87% |
| Change since IPO | 1,185.45% |
Recent News & Updates
Is There Now An Opportunity In Henry Schein, Inc. (NASDAQ:HSIC)?
Sep 23
Is There An Opportunity With Henry Schein, Inc.'s (NASDAQ:HSIC) 49% Undervaluation?
Aug 21Recent updates
Is There Now An Opportunity In Henry Schein, Inc. (NASDAQ:HSIC)?
Sep 23Is There An Opportunity With Henry Schein, Inc.'s (NASDAQ:HSIC) 49% Undervaluation?
Aug 21Henry Schein (NASDAQ:HSIC) Might Be Having Difficulty Using Its Capital Effectively
Aug 01These 4 Measures Indicate That Henry Schein (NASDAQ:HSIC) Is Using Debt Reasonably Well
Jul 09At US$74.94, Is Henry Schein, Inc. (NASDAQ:HSIC) Worth Looking At Closely?
Jun 09Are Investors Undervaluing Henry Schein, Inc. (NASDAQ:HSIC) By 36%?
May 21Henry Schein (NASDAQ:HSIC) Hasn't Managed To Accelerate Its Returns
May 01Here's Why Henry Schein (NASDAQ:HSIC) Can Manage Its Debt Responsibly
Apr 10Estimating The Intrinsic Value Of Henry Schein, Inc. (NASDAQ:HSIC)
Feb 15Returns On Capital At Henry Schein (NASDAQ:HSIC) Have Stalled
Jan 28These 4 Measures Indicate That Henry Schein (NASDAQ:HSIC) Is Using Debt Reasonably Well
Jan 10Is There Now An Opportunity In Henry Schein, Inc. (NASDAQ:HSIC)?
Dec 11Is There An Opportunity With Henry Schein, Inc.'s (NASDAQ:HSIC) 43% Undervaluation?
Nov 04Buy Henry Schein To Receive 'Resiliency Premium' In Equity Portfolios
Aug 25Henry Schein announces $400M increase to stock buyback plan
Aug 18If EPS Growth Is Important To You, Henry Schein (NASDAQ:HSIC) Presents An Opportunity
Aug 09Henry Schein Q2 2022 Earnings Preview
Aug 01Be Wary Of Henry Schein (NASDAQ:HSIC) And Its Returns On Capital
Jul 04Does Henry Schein (NASDAQ:HSIC) Have A Healthy Balance Sheet?
Jun 14Henry Schein: Neutral On Valuation, Covid-19 Sales Slowdown
Jun 09Henry Schein, Inc. (NASDAQ:HSIC) Shares Could Be 45% Below Their Intrinsic Value Estimate
May 27Does Henry Schein (NASDAQ:HSIC) Deserve A Spot On Your Watchlist?
May 10Investors Could Be Concerned With Henry Schein's (NASDAQ:HSIC) Returns On Capital
Apr 04Henry Schein: A Great Play On Medical And Dental Products Trading At An Attractive Price
Mar 07Do Henry Schein's (NASDAQ:HSIC) Earnings Warrant Your Attention?
Feb 08Is Now An Opportune Moment To Examine Henry Schein, Inc. (NASDAQ:HSIC)?
Jan 24Are Investors Undervaluing Henry Schein, Inc. (NASDAQ:HSIC) By 49%?
Jan 09Henry Schein: A Global Leader With A Reasonable Valuation In A Growing Market
Dec 28Some Investors May Be Worried About Henry Schein's (NASDAQ:HSIC) Returns On Capital
Dec 27Here's Why I Think Henry Schein (NASDAQ:HSIC) Is An Interesting Stock
Nov 04Henry Schein Creates Value For Customers And Shareholders
Oct 14Henry Schein (NASDAQ:HSIC) Might Be Having Difficulty Using Its Capital Effectively
Aug 02Is Now An Opportune Moment To Examine Henry Schein, Inc. (NASDAQ:HSIC)?
Jun 29An Intrinsic Calculation For Henry Schein, Inc. (NASDAQ:HSIC) Suggests It's 35% Undervalued
Jun 06Henry Schein nabs $53.4M Strategic National Stockpile contract
May 26Is Henry Schein (NASDAQ:HSIC) A Risky Investment?
May 22Shareholder Returns
| HSIC | US Healthcare | US Market | |
|---|---|---|---|
| 7D | -1.3% | 2.3% | -3.1% |
| 1Y | 9.3% | -4.0% | 15.1% |
Return vs Industry: HSIC exceeded the US Healthcare industry which returned -4% over the past year.
Return vs Market: HSIC underperformed the US Market which returned 15.1% over the past year.
Price Volatility
| HSIC volatility | |
|---|---|
| HSIC Average Weekly Movement | 2.3% |
| Healthcare Industry Average Movement | 5.5% |
| Market Average Movement | 5.5% |
| 10% most volatile stocks in US Market | 14.2% |
| 10% least volatile stocks in US Market | 2.5% |
Stable Share Price: HSIC is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 2% a week.
Volatility Over Time: HSIC's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1932 | 23,000 | Stan Bergman | https://www.henryschein.com |
Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services.
Henry Schein, Inc. Fundamentals Summary
| HSIC fundamental statistics | |
|---|---|
| Market Cap | US$9.55b |
| Earnings (TTM) | US$458.00m |
| Revenue (TTM) | US$12.60b |
20.8x
P/E Ratio0.8x
P/S RatioIs HSIC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HSIC income statement (TTM) | |
|---|---|
| Revenue | US$12.60b |
| Cost of Revenue | US$8.74b |
| Gross Profit | US$3.85b |
| Other Expenses | US$3.40b |
| Earnings | US$458.00m |
Last Reported Earnings
Jul 01, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 3.51 |
| Gross Margin | 30.59% |
| Net Profit Margin | 3.64% |
| Debt/Equity Ratio | 30.1% |
How did HSIC perform over the long term?
See historical performance and comparison